2025-08-14 - Analysis Report
Okay, here's an analysis of Intuitive Surgical (ISRG) based on the provided data, presented in English with a focus on key numbers and straightforward interpretations.

**1. Performance vs. S&P 500 (VOO)**

*   **Ticker:** ISRG
*   **Company Description:** Intuitive Surgical Inc. designs, manufactures, and markets robotic surgical systems.
*   **ISRG Cumulative Return:** 62.13%
*   **VOO Cumulative Return:** 86.23%
*   **Absolute Divergence:** 27.5
*   **Relative Divergence:** 23.8

**Analysis:** ISRG has underperformed the S&P 500 (VOO) over the analyzed period, with a 27.5% absolute divergence in cumulative returns. The relative divergence of 23.8 suggests ISRG's underperformance is towards the lower end of its historical range compared to VOO.

*   **Alpha, Beta Analysis**

| Year       | CAGR   | MDD    | Alpha  | Beta   | Cap(B) |
| ---------- | ------ | ------ | ------ | ------ | ------ |
| 2015-2017  | -7.0%  | 8.7%   | -9.0%  | 0.7    | 43.6   |
| 2016-2018  | 11.0%  | 63.1%  | 16.0%  | -0.0   | 57.2   |
| 2017-2019  | 32.0%  | 63.1%  | 9.0%   | 0.0    | 70.6   |
| 2018-2020  | 57.0%  | 63.1%  | 30.0%  | -0.0   | 97.8   |
| 2019-2021  | 81.0%  | 62.8%  | 32.0%  | 0.0    | 128.8  |
| 2020-2022  | 10.0%  | 69.8%  | 3.0%   | 0.0    | 95.1   |
| 2021-2023  | 8.0%   | 72.7%  | -12.0% | 1.6    | 120.9  |
| 2022-2024  | 30.0%  | 72.7%  | 3.0%   | 1.7    | 187.1  |
| 2023-2025  | 32.0%  | 72.7%  | -20.0% | 0.8    | 172.9  |

**Analysis:**

*   **CAGR:** The Compounded Annual Growth Rate shows fluctuating performance, with periods of negative growth (2015-2017) and high growth (2019-2021).
*   **MDD:** The Maximum Drawdown indicates significant potential losses, consistently above 60% in most periods. This suggests high volatility and risk.
*   **Alpha:** Alpha represents the excess return compared to a benchmark. Periods with negative alpha (e.g., 2015-2017, 2021-2023, 2023-2025) mean ISRG underperformed its benchmark during those times.
*   **Beta:** Beta measures the stock's volatility relative to the market. A beta of 1.6 and 1.7 in the 2021-2023 and 2022-2024 periods, respectively, indicates that ISRG was more volatile than the market during those times.
*   **Cap(B):** Market capitalization has generally increased over time, reflecting the company's growth.

**2. Recent Stock Price Movement**

*   **Current Price:** 482.35
*   **Previous Close:** 478.19
*   **Change:** 0.87 (Indicates a slight increase)
*   **5-day Moving Average:** 474.46
*   **20-day Moving Average:** 490.53
*   **60-day Moving Average:** 519.40

**Analysis:** The stock price is currently above its 5-day moving average but below its 20-day and 60-day moving averages. This suggests a potential short-term upward trend, but the longer-term trend may still be downwards or sideways. The recent price change of 0.87 is relatively small, not indicating a significant event.

**3. Market Risk Indicators & Expected Return**

*   **Market Risk Indicator (MRI):** 0.3234 (Low Risk)
*   **RSI:** 45.07 (Neutral - neither overbought nor oversold)
*   **PPO:** -0.0159 (Slightly negative, indicating a potential downtrend in momentum)
*   **Hybrid Signal:** cash_69%_Sell 69.6% of holdings (288 shares - Caution - MRI:0.35)
*   **20-day Relative Divergence Change:** -4.0 (Short-term decline in relative performance)
*   **Expected Return:** 173.1% (Long-term, relative to S&P 500)

**Analysis:** The MRI suggests low market risk. However, the hybrid signal recommends selling a significant portion of holdings, indicating caution. The negative change in relative divergence supports this cautious outlook. The high expected return suggests strong potential long-term outperformance relative to the S&P 500 *if* the investment horizon is long-term (2+ years) and the investor is willing to dollar-cost average.

**4. Recent News & Events**

*   **2025-08-11:** Major business developments, regulatory changes, or market events.
*   **2025-08-14:** Analyst discussions about performance in the context of industry trends and global economic factors.
*   **2025-08-10:** Notable stock volatility due to recent news, earnings reports, or executive actions.
*   **2025-08-13:** Market experts highlight risks and opportunities, advising monitoring of news and announcements.

**Analysis:** Recent news indicates potential volatility and significant events impacting ISRG. Investors should carefully monitor news and company announcements.

**5. Recent Earnings Analysis**

| Date       | EPS  | Revenue   |
| ---------- | ---- | --------- |
| 2025-07-23 | 1.84 | 2.44 B$   |
| 2025-04-23 | 1.95 | 2.25 B$   |
| 2024-10-18 | 1.59 | 2.04 B$   |
| 2024-07-19 | 1.48 | 2.01 B$   |
| 2025-07-23 | 1.48 | 2.01 B$   |

**Analysis:**  EPS and revenue have generally been increasing over the reported quarters. However, the last record 2025-07-23 has the same date, 1.48 as EPS and 2.01 B$ as revenue, this may be error data.

**6. Financial Information**

*Revenue and Profitability:*

| Quarter    | Revenue   | Profit Margin |
| ---------- | --------- | ------------- |
| 2025-06-30 | $2.44B   | 66.31%       |
| 2025-03-31 | $2.25B   | 64.69%       |
| 2024-12-31 | $2.41B   | 68.04%       |
| 2024-09-30 | $2.04B   | 67.41%       |
| 2024-06-30 | $2.01B   | 68.30%       |

*Capital and Profitability:*

| Quarter    | Equity     | ROE      |
| ---------- | ---------- | -------- |
| 2025-06-30 | $17.85B   | 3.69%    |
| 2025-03-31 | $17.11B   | 4.08%    |
| 2024-12-31 | $16.43B   | 4.17%    |
| 2024-09-30 | $15.58B   | 3.63%    |
| 2024-06-30 | $14.71B   | 3.58%    |

**Analysis:**

*   **Revenue:** Revenue has generally increased over the past several quarters, showing solid growth.
*   **Profit Margin:** Profit margins remain very strong, consistently above 64%, indicating excellent operational efficiency.
*   **Equity:** Total equity has increased steadily, reflecting the company's growing net worth.
*   **ROE:** Return on Equity (ROE) has been relatively stable, fluctuating between 3.58% and 4.17%, indicating consistent profitability relative to shareholder equity.

**7. Overall Summary**

Intuitive Surgical (ISRG) presents a mixed picture.

*   **Positives:** The company demonstrates strong revenue growth, excellent profit margins, and a solid balance sheet. Long-term growth prospects are promising.
*   **Negatives:**  ISRG has underperformed the S&P 500 recently and shows high volatility. Recent market events may introduce uncertainty. A cautious hybrid signal suggests potential downside risk.

**Recommendation:** Given the contradictory signals, a cautious approach is warranted. Monitor news and company announcements closely. While the long-term expected return is high, consider dollar-cost averaging to mitigate the risk of short-term volatility.
